Pfizer Announces COVID-19 Vaccine Trial with 90% Effectiveness

Monday morning’s announcement from Pfizer about its vaccine against COVID-19 was met with cheers and a bump in stock prices, but there is disagreement on how Operation Warp Speed factored into Pfizer’s development. What are the experts saying?


Somewhat unexpected news greeted America Monday morning as Pfizer announced its coronavirus vaccine candidate has been shown to be 90% effective in trials.


reporting from the left side of the aisle


  • In its reporting, The New York Times emphasized Pfizer was not part of the Trump Administration’s Operation Warp Speed, which provided research and development funding and a compressed regulatory framework for covid-19 vaccine trials.
  • Newsweek reported that, while Pfizer did not participate in Operation Warp Speed’s R&D efforts, the drug company did reach an agreement with the government in July to provide 100 million doses for nearly $2 billion to be given to Americans at no cost.
  • Contrary to much of the coverage, NPR poured cold water on the news, providing skeptical coverage on the realities of its long-term effectiveness and the need for more trials and data before the US Food and Drug Administration can greenlight the vaccine for use.




Return to Freespoke

© Dallas Gerber, 2020